This paper reported a case of an eighteen-month old Nigerian girl with 11-beta-hydroxylase-deficient congenital adrenal hyperplasia who presented with hypertension and heart failure. The hypertension resolved with steroid therapy. Her blood pressure has remained normal on maintenance prednisolone. The abnormal external genitalia was probably missed at the private hospital where the child was born as it was not mentioned to the parents before discharge on the second day of life. When the child presented at about the age of two months with an enlarged clitoris, she was referred to a paediatric surgeon in another private hospital. It would have been more appropriate to refer her to a paediatric endocrinologist in the nearest tertiary healthcare institution. This case highlights the importance of thorough physical examination of the external genitalia at birth and appropriate referral. The management challenges encountered in the care of this patient included lack of laboratory facilities for diagnosis and monitoring of therapy, non-availability of necessary drugs (oral hydrocortisone) and late presentation.
Introduction
C ongenital adrenal hyperplasia (CAH) due to 11-beta-hydroxylase defi ciency is an autosomal recessively inherited disorder of steroidogenesis, characterized biochemically by increased concentrations of deoxycorticosterone, 11 deoxycortisol and delta 4-androstenedione and decreased plasma renin concentration 1 . Clinically it is associated with hypertension and genital ambiguity in affected females 1 . Approximately two-third of patients with 11-beta hydroxylase defi ciency become hypertensive and this may take several years 2 . Hypertension is the single clinical feature distinguishing 11-beta-hydroxylase defi ciency from 21-hydroxylase defi ciency (commonest form of CAH, accounting for 90% of cases) 3 . Although 11-beta-hydroxylase defi cient CAH is uncommon, it should be considered in the differential diagnosis of hypertension with virilisation in any prepubecent female.
11-beta-hydroxylase defi ciency accounts for approximately 5% of all cases of CAH with an estimated incidence of 1 in 100,000 to 250,000 live births 2 . Defi ciency of 11-beta-hydroxylase enzyme is due to mutation in the steroid 11-beta-hydroxylase CYP11B1 gene located on chromosome locus 8q21-22 3 . In 11-beta-hydroxylase defi cient CAH, cortisol and corticosterone are defi cient with overproduction of 11-deoxycortisol and 11-deoxycorticosterone. The precursor hormones are shunted into the androgen pathway causing prenatal and postnatal virilisation.
The accumulation of 11-deoxycorticosterone results in salt and water retention with increased plasma volume and hypertension. Glucocorticoid administration is effective in reversing all the abnormalities and inducing remission 3 .
In developing countries, laboratory facilities for accurate and specifi c diagnosis of endocrine disorders are lacking, thereby adversely affecting management. Where the facility is available, the cost is prohibitive given the wide-spread poverty in our country.
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The purpose of this paper is to report a case of 11-beta-hydroxylase defi cient CAH in a Nigerian girl with steroid responsive hypertension and heart failure and promote its awareness among medical personnel.
The Case
The patient was delivered in a private hospital in Benin City and was discharged home on the second day of life. The health care providers in the private hospital did not mention to the mother that the external genitalia were abnormal. Following discharge from the hospital, the mother also did not notice any abnormality of the external genitalia. At the age of two months, the maternal grandmother noticed a protrusion from the genitals. The patient was then taken to the private hospital where she was born and was referred to another private hospital being managed by a paediatric surgeon. The parents defaulted from follow up in the hope that the protrusion will regress with time. However, the protrusion continued to increase in size and this forced the parents to consult again the paediatric surgeon at his private clinic at the age of 12 months. She had a clitoridectomy at the age of 12 months and was discharged home two weeks later, apparently well. She was not placed on steroid. However, six months later, the patient presented again to the paediatric surgeon with facial swelling and diffi culty in breathing which prompted referral to Children's Emergency Room (CHER), University of Benin Teaching Hospital (UBTH), Benin City as a case of bronchopneumonia. Evaluation at the CHER, UBTH revealed no history of maternal ingestion of androgens during pregnancy. She is the younger of two children in the family. The older sibling is a boy. There was no maternal history of hirsutism, genital abnormality or menstrual irregularity. Physical examination revealed a child with an advanced muscular development, a weight of 11.8 kg and a height of 70 cm. The occipito-frontal circumference was 52 cm. She had facial puffi ness, tachypnoea (respiratory rate 72 cycles/ min), dyspnoea and fi ne basal crepitation. Examination of the cardiovascular system revealed tachycardia (pulse rate 168/min), hypertension (blood pressure 140/100 mmHg) and normal heart sounds. There was no murmur. She had a tender hepatomegaly (5 cm below the right costal margin). Genital examination revealed amputated stump of the clitoris with normal labia majora and minora. The urethral meatus was below the amputated clitoris. The vaginal orifi ce was well formed. Laboratory investigation revealed normal serum urea and electrolytes values. The results of other investigations are shown in Table 1 . A diagnosis of 11-beta-hydroxylase defi cient CAH with heart failure was reached at. The differential diagnosis considered were 21-hydroxylase defi cient CAH, 17-hydroxylase defi cient CAH, and Cushing syndrome. The patient was commenced on intravenous hydrocortisone which was later changed to oral prednisolone (because of diffi culty in procuring oral hydrocortisone). Hydrochlorothiazide therapy was also instituted. Antihypertensive drug was not administered. The hypertension and heart failure resolved without specifi c antihypertensive therapy. 
Discussion
In this patient, the diagnosis of 11-beta-hydroxylasedefi cient CAH with heart failure was based on evidence of virilisation, muscular physique, hypertension, tachycardia, tachypnoea, tender hepatomegaly, and resolution of the hypertension following steroid therapy. The elevated serum levels of 17-hydroxyprogesterone, cardiomegaly seen on chest radiograph and absence of salt wasting were all in support of our diagnosis. One of the tasks in this patient was to determine the genetic sex by distinguishing between a virilized female and a feminized male. This task was successfully accomplished by the karyotype which showed presence of Barr bodies on buccal smear examination and a normal internal female reproductive system (ovaries, fallopian tubes and uterus) on pelvic ultrasonography, consistent with a genetic female. Our diagnosis of 11-betahydroxylase-defi cient CAH was based on the presence of hypertension (which resolved on steroid therapy only) and signs of hyperandrogenism. This diagnostic approach is reinforced by the report of Griqoresen Sido et al, 5 in which fi ve patients diagnosed clinically as having 11-beta-hydroxylase defi ciency on the same clinical basis were later confi rmed on molecular analysis to have 11-beta-hydroxylase defi ciency. The differential diagnoses include 17-alpha-hydroxylase defi cient CAH, 21-hydroxylase-defi cient CAH and Cushing syndrome. Although hypertension is a feature of 17-alphahydroxylase defi cient CAH, sexual infantilism rather than virilisation is usually seen in females with the condition 2 . In this patient, there was virilisation making 17-alphahydroxylase defi cient CAH less likely. Epidemiologically, 21-hydroxylase-defi cient CAH accounts for about 90% of all cases of CAH 2 and was therefore, considered one of the differential diagnoses. Hypertension is not a usual clinical feature of 21-hydroxylase-defi cient CAH, therefore its presence in the index patient made the diagnosis of 21-hydroxylase defi ciency less likely. The normal values of serum potassium and bicarbonate obtained in this patient negated the diagnosis of 21-hydroxlase defi ciency. Although Cushing syndrome may be associated with hypertension and virilisation, particularly if it is due to adrenal carcinoma, 3 absence of cushingoid facies and the good response of the hypertension to steroid therapy negated its diagnosis. In addition, there was no evidence of weight loss both historically and on physical examination. The absence of abdominal mass on physical examination which was further confi rmed by ultrasonography and the elevated serum DHEAS were all against the diagnosis of Cushing Syndrome.
In this patient, hypertension and heart failure were observed. This is not surprising as similar observation has been documented in previous studies among patients with 11-beta-hydroxylase-defi cient CAH 6, 7, 8 . The hypertension is thought to be due to the accumulation of deoxycorticosterone resulting in sodium and water retention, increased plasma volume which in turn, causes hypertension 3 . As in previous reports 1, 7, 8 , glucocorticoid therapy was effective in reversing all the abnormalities and inducing remission in the index patient. The control of hypertension with glucocorticoid therapy is as a result of the feedback inhibition of the hypothalamus and the pituitary gland, resulting in a reduction in ACTH secretion. As a consequence, the production of deoxycorticosterone as well as androgens is reduced, lowering blood pressure and preventing further virilization. The virilization and advanced muscular development in our patient were as a result of cortisol precursor hormones which were shunted into the androgenic pathway causing prenatal and postnatal virilization 3 .
The index patient illustrated some of the management challenges encountered in developing countries among children with an aberrant external genitalia. Such challenges include lack of laboratory facilities for diagnosis and monitoring of therapy, nonavailability of necessary drugs and late presentation with its sequelae. First, the aberrant external genitalia of this patient were missed at the health facility where the child was born, suggesting inadequate examination of the external genitalia by the healthcare providers. Similar observation has been documented in previous studies 9, 10, 11 . Following the discovery at home of the enlarged clitoris and the subsequent presentation at the private hospital where the child was born, the physician referred the patient to the paediatric surgeon rather than the paediatric endocrinologist. This decision resulted in continued exposure of the child to high levels of androgenic hormones, resulting in further virilisation postnatally. Had the patient been referred to the paediatric endocrionologist initially, therapeutic measures to control the continued accumulation of androgenic hormones would have been instituted, preventing further postnatal virilization. The long delay (9 months) before medical help was sought even after the enlarged clitoris was discovered by the maternal grandmother compounded the situation. The mother had hoped that with time, the enlarged clitoris will regress spontaneously, illustrating the gross lack of disease awareness in our local community. Similar observation concerning poor awareness has been reported in a previous study in Benin City 11 . The potential consequences of late presentation include precocious puberty and short stature in adulthood. Lack of facility for defi nitive diagnosis, such as determination of specifi c enzyme defect, and even biochemical follow up to monitor therapy is very common in most developing countries, including Nigeria 4 . Where the facility for hormone assay is available, the cost is prohibitive. The healthcare providers paid for most of the investigation performed in this patient. Procurement of oral hydrocortisone (drug of choice) was very diffi cult. Most pharmacy stores in Benin City do not stock oral hydrocortisone, forcing us to use prednisolone (which is less effective) as an alternative.
